Pediatric Mycoplasma Pneumoniae Clinical Data with Biomarkers, April-May 2024

147 pediatric patients with Mycoplasma pneumoniae pneumonia admitted to the Children’s Hospital of Fudan University, Shanghai, China, between April 1, 2023 and May 31, 2024. Demographic, clinical, and laboratory data were collected, including biomarker sST2 and inflammatory markers. The dataset was created by Fangying Cheng and is licensed under CC-BY-4.0.

Use Cases

• Predicting severe in-hospital adverse events based on biomarker sST2 levels.
• Analyzing correlations between biomarker sST2 and inflammatory markers like CRP, PCT, and IL-6.
• Evaluating associations between biomarker levels and clinical complications, such as co-infections or pulmonary/extrapulmonary complications.
• Investigating relationships between biomarker levels and hospital length of stay or preadmission fever duration.

Strengths

• Includes data for 147 pediatric patients.
• Contains biomarker sST2 levels and other inflammatory markers (CRP, PCT, IL-6) and blood cell counts.
• Covers a specific two-month time range (April-May 2024).

Limitations

• Column-level documentation is absent; field semantics must be inferred after download.
• Row count is unknown, which may limit suitability assessment.
• Data may reflect geographic bias inherent to a single hospital in Shanghai.

Provenance

Source

Children’s Hospital of Fudan University, Shanghai, China.

Collection Method

Retrospective analysis of admitted patients.

Time Range

April 1, 2023 to May 31, 2024.

Freshness

Last updated 2026-04-17 17:43:39; freshness should be verified.

Geography

Shanghai, China.